| NCT ID | NCT02540915 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Chest Wall and Spinal Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2013-11 |
| Primary Completion | 2050-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2013-11 with a primary completion date of 2050-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Pediatric Spine Foundation is a registry designed to assist spine surgeons to efficiently identify and track patients with chest wall and spinal disorders.
Eligibility Criteria
Inclusion Criteria: * All patients 17 and under that are being treated at Children's Hospital Colorado Orthopaedic department for a chest wall deformity, spine deformity and/or spinal disorder. However, patients must be/have been 11 or under at their initial treatment/evaluation at Children's Hospital Colorado to be included in this study. Exclusion Criteria: * Enrollment in another spine registry
Contact & Investigator
Sumeet Garg, MD
PRINCIPAL INVESTIGATOR
Children's Hopsital Colorado
Frequently Asked Questions
Who can join the NCT02540915 clinical trial?
This trial is open to participants of all sexes, up to 17 Years, studying Chest Wall and Spinal Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02540915 currently recruiting?
Yes, NCT02540915 is actively recruiting participants. Contact the research team at tyler.feddema@childrenscolorado.org for enrollment information.
Where is the NCT02540915 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT02540915 clinical trial?
NCT02540915 is sponsored by University of Colorado, Denver. The principal investigator is Sumeet Garg, MD at Children's Hopsital Colorado. The trial plans to enroll 5,000 participants.